Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States.

Printable Copy

Chesson HW, Meites E, Ekwueme DU, Saraiya M, Markowitz LE.

Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States.

Vaccine. 2018 Jul 5;36(29):4362-4368. doi: 10.1016/j.vaccine.2018.04.071.

https://www.sciencedirect.com/science/article/pii/S0264410X18305784?via%3Dihub